Epitel
Epitel is a digital health company focused on modernizing brain health solutions, specifically for seizure monitoring and detection. Their flagship product, REMI™, is a wireless EEG monitoring system that leverages REMI Vigilenz™ AI for event detection. REMI™ offers accurate, fast, and easy-to-use EEG recordings that can be initiated within minutes, allowing patients to move freely without wires. The system is designed for both healthcare facilities and ambulatory use, simplifying the EEG monitoring process and improving the ability to detect potential electrographic seizure activity. It integrates with familiar platforms like Persyst™ Mobile and is reimbursable using existing codes. The company is headquartered in Salt Lake City, UT.
Epitel
Epitel is a digital health company focused on modernizing brain health solutions, specifically for seizure monitoring and detection. Their flagship product, REMI™, is a wireless EEG monitoring system that leverages REMI Vigilenz™ AI for event detection. REMI™ offers accurate, fast, and easy-to-use EEG recordings that can be initiated within minutes, allowing patients to move freely without wires. The system is designed for both healthcare facilities and ambulatory use, simplifying the EEG monitoring process and improving the ability to detect potential electrographic seizure activity. It integrates with familiar platforms like Persyst™ Mobile and is reimbursable using existing codes. The company is headquartered in Salt Lake City, UT.
TL;DR
Headquarters: Salt Lake City, UT
Flagship product: REMI wireless Remote EEG Monitoring System
Regulatory status: REMI received FDA clearance (first clearance 2021)
Total disclosed funding: USD 20,400,000
Recent round: Series A (announced 2022-02-16)
Company Overview
Problem Domain
Seizure monitoring and brain health (EEG monitoring and event detection)
Founded
2017
Industry
Digital health / Neurotechnology
Funding Track Record
Series A announced Feb 16, 2022; participating investors include Dexcom Ventures, OSF Ventures, MedMountain Ventures, Wavemaker Three-Sixty, SLC Angels, and others.
Investor Signal
“Participating investors include corporate health investors and healthcare system venture arms (Dexcom Ventures, OSF Ventures, Catalyst Health Ventures, Genoa Ventures).”